Page results
- 
                                    
                                                                            
An antibody treatment trialled at UCLH cuts the risk of developing symptomatic COVID-19 by 77%.
 - 
                                    
                                                                            
After almost six months and more than 120,000 vaccinations the Islington Business Design Centre closes as a vaccination centre today (20 August 2021).
 - 
                                    
                                                                            
Pop-up clinics in Islington will make it easier for people who are eligible for the Covid-19 vaccine – especially those who are elderly, homeless, vulnerable or in need of support – to get it closer to home.
 - 
                                    
                                                                            
UCLH Director of Research and Director of the UCLH BRC Professor Bryan Williams has received an award for outstanding contributions to research in the field of hypertension (high blood pressure).
 - 
                                    
                                                                            
Two directors have joined the UCLH Board – Liz O’Hara, director of workforce and Laura Churchward, director of strategy.
 - 
                                    
                                                                            
“Vaccines do not kill, the virus does”: that was the message from local leaders from a variety of different faiths during an event at the newly opened vaccination centre at the Business Design Centre in Islington.
 - 
                                    
                                                                            
Thrombotic Thrombocytopenia Purpura (TTP) is a rare disorder of the blood coagulation system.
 - 
                                    
                                                                            
The earliest brain changes due to Huntington’s disease can be detected 24 years before clinical symptoms show, according to a new UCL-led study.
 - 
                                    
                                                                            
Want to find out more? Have an idea or educational content you wish to contribute? Interested in partnering or working with us? Use the details below to contact the team.
 - 
                                    
                                                                            
If ataxia runs in your family, you can get tested to see if you have the genetic mistake for it Ataxia is a health condition that causes problems with movement…
 
File results
- 
                                                                            
FOI/2022/0171 - Consultant-led Referral to Treatment (RTT), outpatients and Patient Initiated Follow-up (PIFU)
 - 
                                                                            
FOI/2022/0186 - Gender neutral toilets at the Trust
 - 
                                                                            
FOI/2022/0211 - Enteral feeding machine mechanical insufflator
 - 
                                                                            
FOI/2022/0216 - Inventory management system
 - 
                                                                            
FOI/2022/0217 - Medications for dermatological conditions
 - 
                                                                            
FOI/2022/0227 - Number of cancer trackers and cancer MDT co-ordinators at Trust
 - 
                                                                            
FOI/2022/0246 - Adult haematology services
 - 
                                                                            
FOI/2022/0247 - Care Axial SpA referrals to rheumatology
 - 
                                                                            
FOI/2022/0249 - Robotic process automation/ intelligent automation technology
 - 
                                                                            
FOI/2022/0263 - Rheumatology prescriptions